Contractor
BOSTON MEDICAL CENTER CORPORATION
- UEI
- JZ8RQC4EMDZ5
- Parent UEI
- JZ8RQC4EMDZ5
- Resolved by
- uei
- Confidence
- 1.000
Active from Sep 25, 2007 to Oct 8, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36C24125C0070 EDUCATION COST SHARING | Department of Veterans Affairs | MA | Sep 25, 2025 | $350,496 |
| 36C24126C0007 OPHTHALMOLOGY PHYSICIAN SERVICES | Department of Veterans Affairs | MA | Jan 30, 2026 | $127,142 |
| 75D30126F00003 CISA HOME LAIV STUDY - CONTRIBUTING SITE EO 14398 | Department of Health and Human Services | MA | Sep 25, 2026 | $784,899 |
| HHSD200200723690C RETAINING HIV POSITIVE PATIENTS IN CLINICAL SETTING | Department of Health and Human Services | GA | Sep 25, 2007 | $2,654,973 |
| 75D30123F00001 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | Department of Health and Human Services | MA | Sep 27, 2023 | $861,867 |
| 75N94021D00003 CLINICAL RESEARCH SITES FOR THE NIAAA MEDICATIONS DEVELOPMENT CLINICAL INVESTIGATIONS NETWORK FOR THE TREATMENT OF ALCOHOL USE DISORDER | Department of Health and Human Services | — | Mar 10, 2021 | — |
| 75N94021F00001 CORE FUNCTION ACTIVITIES TASK ORDER FOR ADVISORY SERVICES AND ADMINISTRATIVE REPORTING | Department of Health and Human Services | MA | Jul 9, 2026 | $118,843 |
| 75N94020F00001 NICHD: R&D: TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES: SEVERABLE | Department of Health and Human Services | MA | Mar 25, 2026 | $72,405 |
| 75N94020D00004 NICHD: R&D: TO CONDUCT PHASE I, II, III OR IV CONTRACEPTIVE TRIALS IN WOMEN, TREATMENT TRIALS OF GYNECOLOGIC CONDITIONS SUCH AS ENDOMETRIOSIS OR LEIOMYOMATA, AND DEVELOPMENT OF RESEARCH PROTOCOLS ON A TASK ORDER BASIS: NON-SEVERABLE | Department of Health and Human Services | — | Jul 1, 2026 | — |
| 75D30123D17920 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | Department of Health and Human Services | — | Sep 26, 2023 | — |
| 75N94023F00001 NICHD: R&D: OVAPRENE VAGINAL DEVICE CLINICAL TRIAL PHASE 1: NON-SEVERABLE | Department of Health and Human Services | MA | Apr 21, 2026 | $113,357 |
| 75N94025F00001 NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE | Department of Health and Human Services | MA | Apr 21, 2026 | $599,807 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier JZ8RQC4EMDZ5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.